ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: ETIOLOGY AND PHARMACOTHERAPY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NOURBALA A.A.; AKHOUNDZADEH SH.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ARCHIVES OF IRANIAN MEDICINE Year:2006 | Volume:9 | Issue:4 Page(s): 374-380

Download Full-Text

View:

513

Download:

373

Cites:

Information Journal Paper

Title

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: ETIOLOGY AND PHARMACOTHERAPY

Author(s)

NOURBALA A.A. | AKHOUNDZADEH SH. | Issue Writer Certificate

Keywords

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)

ALTERNATIVE MEDICINE

ETIOLOGY

PHARMACOTHERAPY

STIMULANTS

Abstract

Attention-deficit/hyperactivity disorder is a common neurobehavioral disorder of childhood and adolescence. The ETIOLOGY of attention-deficit/hyperactivity disorder is not well understood. Neurochemical studies suggest, alterations in catecholaminergic, mainly dopaminergic and noradrenergic, transmitter functions markedly contribute to the symptoms of this disorder. The symptoms of attention-deficit/hyperactivity disorder are significantly ameliorated by the agents that specifically influence these neurotransmitters. Animal studies implicate areas of the brain in which these neurotransmitters are most dominant. Psychostimulant medications are generally the first choice in the treatment of attention-deficit/hyperactivity disorder. Approximately 70% of the children treated show improvement in the primary attention-deficit/hyperactivity disorder symptoms and in comorbidity such as conduct disorder, although the benefits may not hold beyond two years. Despite the well-established efficacy and safety of STIMULANTS for attentiondeficit/ hyperactivity disorder, ALTERNATIVE MEDICINEs are still needed for several reasons. About 30% of children and adolescents with this disorder may not respond to STIMULANTS or may be unable to tolerate potential adverse events such as decreased appetite, mood lability and sleep disturbances. Although STIMULANTS do not increase the risk for later substance abuse in attentiondeficit/ hyperactivity disorder, concerns have been raised about special prescription rules and a potential for abuse by persons other than the attention-deficit/hyperactivity disorder subjects. This review focuses on ETIOLOGY, assessment, and treatment of attention-deficit/hyperactivity disorder.

Cites

No record.

References

No record.

Cite

APA: Copy

NOURBALA, A.A., & AKHOUNDZADEH, SH.. (2006). ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: ETIOLOGY AND PHARMACOTHERAPY. ARCHIVES OF IRANIAN MEDICINE, 9(4), 374-380. SID. https://sid.ir/paper/280144/en

Vancouver: Copy

NOURBALA A.A., AKHOUNDZADEH SH.. ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: ETIOLOGY AND PHARMACOTHERAPY. ARCHIVES OF IRANIAN MEDICINE[Internet]. 2006;9(4):374-380. Available from: https://sid.ir/paper/280144/en

IEEE: Copy

A.A. NOURBALA, and SH. AKHOUNDZADEH, “ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: ETIOLOGY AND PHARMACOTHERAPY,” ARCHIVES OF IRANIAN MEDICINE, vol. 9, no. 4, pp. 374–380, 2006, [Online]. Available: https://sid.ir/paper/280144/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops